Anne Madroszyk

4PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 03, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.

Thomas Pierre Walter, Julien Mazieres, Josiane Otto

|Sep 27, 2022
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.

Philippe Rochigneux, Aaron Lisberg, Alejandro Garcia

|Jul 08, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.

Fabrice Barlesi, Pascale Tomasini, Maryam Karimi

|May 25, 2021
First-Line Afatinib plus Cetuximab for <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study.

Alexis B Cortot, Anne Madroszyk, Etienne Giroux-Leprieur

Pageof 1